Description
RXPO Creative Competition 2025 offers Poster, Essay, Scientific Paper, and Videography contests for students across Indonesia, complete with official requirements and timelines.
The RXPO Creative Competition 2025 is officially open and invites all active students from various Indonesian higher education institutions to participate in four creative categories: Poster, Essay, Scientific Paper, and Videography. This competition aims to promote innovation, creativity, and student competence through original works that meet the official guidelines.
Competition Categories and Key Requirements
1. Poster
• Participants must be active students with a valid Student ID.
• Teams may consist of up to three members.
• Submitted posters must be original and unpublished.
Poster Timeline
Registration & Submission: 11 Oct – 06 Nov 2025
Abstract Announcement: 07 Nov 2025
Full Paper Submission: 07–21 Nov 2025
Jury Evaluation: 23–27 Nov 2025
Finalists Announcement: 28 Nov 2025
Final Round: 29 Nov 2025
Winners Announcement: 01 Dec 2025
2. Essay
• Open to active students and alumni of the Faculty of Pharmacy USU.
• Essays must be original academic works.
Essay Timeline
Submission: 11 Oct – 01 Nov 2025
Abstract Announcement: 02 Nov 2025
Full Paper: 07–21 Nov 2025
Evaluation: 23–27 Nov 2025
Final Round: 29 Nov 2025
Winners Announcement: 01 Dec 2025
3. Scientific Paper (KTI)
• Open to active students and alumni of the Faculty of Pharmacy USU.
• Papers must be original scientific analyses.
KTI Timeline
Abstract Submission: 11 Oct – 06 Nov 2025
Abstract Announcement: 07 Nov 2025
Full Paper: 07–21 Nov 2025
Evaluation: 23–27 Nov 2025
Final Round: 29 Nov 2025
Winners Announcement: 01 Dec 2025
4. Videography
• Open to active students and alumni of the Faculty of Pharmacy USU.
• Videos must be original and relevant to the theme.
Videography Timeline
Submission: 11 Oct – 06 Nov 2025
Evaluation: 07–21 Nov 2025
Final Round: 29 Nov 2025
Winners Announcement: 01 Dec 2025
Prize
Each category offers cash prizes and certificates for the winners.